v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue (note 12) $ 5,337 $ 2,621
Cost of sales 1,505 768
Gross profit 3,832 1,853
Operating expenses    
Research and development 5,262 4,808
Selling, general and administrative 6,591 8,211
Total operating expenses 11,853 13,019
Operating loss 8,021 11,166
Other (income) expenses    
Net finance (income) expense (377) (445)
Net foreign exchange (gain) loss (616) (38)
Total other (income) expenses (993) (483)
Net loss before income taxes 7,028 10,683
Income tax expense 27 41
Deferred tax expense (recovery) (2)  
Total income tax expense 25 41
Net loss attributed to shareholders for the period 7,053 10,724
Item that may be reclassified to (income) loss    
Foreign currency translation adjustment 1,005 (103)
Net loss and other comprehensive loss for the period $ 8,058 $ 10,621
Loss per share (note 13)    
Basic net loss per common share (in dollars per share) $ 0.19 $ 0.36
Diluted net loss per common share (in dollars per share) $ 0.19 $ 0.36
Basic weighted average common shares outstanding (in shares) 36,297,684 30,041,735
Diluted weighted average common shares outstanding (in shares) 36,297,684 30,041,735
Recurring - non-capital    
Revenue (note 12) $ 2,474 $ 1,801
Capital equipment    
Revenue (note 12) $ 2,863 $ 820

Source